Favorable prognosis in patients with T1a/T1bN0 triple-negative breast cancers treated with multimodality therapy (Q56928413)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392492%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

title

Favorable prognosis in patients with T1a/T1bN0 triple-negative breast cancers treated with multimodality therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392492%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392492%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Mark Robson

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392492%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

Gaorav Gupta

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392492%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Yong Hannah Wen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392492%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Edi Brogi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392492%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Tiffany Traina

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392492%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Alice Y Ho

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392492%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Tari A King

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392492%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Carmen A Perez

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392492%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Sujata M Patil

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392492%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Katherine H Rogers

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392492%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Monica Morrow

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392492%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Clifford A Hudis

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392492%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Simon N Powell

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392492%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

language of work or name

English

0 references

publication date

5 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392492%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392492%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392492%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392492%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

4944-4952

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392492%20AND%20SRC:MED&resulttype=core&format=json

Nation-wide breast cancer screening in The Netherlands: results of initial and subsequent screening 1990-1995. National Evaluation Team for Breast Cancer Screening.

25 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27480

Effect of screening and adjuvant therapy on mortality from breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27480

Triple-negative breast cancer: clinical features and patterns of recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27480

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27480

Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27480

Estrogen/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a,bN0 breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27480

Triple negativity and young age as prognostic factors in lymph node-negative invasive ductal carcinoma of 1 cm or less

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27480

Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27480

Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27480

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27480

Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27480

A basal epithelial phenotype is more frequent in interval breast cancers compared with screen detected tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27480

Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27480

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27480

Pattern of metastatic spread in triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27480

Locoregional Relapse and Distant Metastasis in Conservatively Managed Triple Negative Early-Stage Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27480

inferred from DOI database lookup

7 January 2021

based on heuristic

Overall Survival and Cause-Specific Mortality of Patients With Stage T1a,bN0M0 Breast Carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27480

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCR.27480

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22392492%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference